Transcranial Direct Current Stimulation Associated With Peripheral Electrical Stimulation for Pain Control in Individuals With Sickle Cell Disease
试验速览
- 阶段
- 2 期
- 入组人数
- 120
- 试验地点
- 2
- 主要终点
- Change in pain intensity
研究概览
简要总结
So far, no study investigated the safety and efficacy analgesic of transcranial direct current stimulation (tDCS) associated to peripheral electrical stimulation (PES) in individuals with SCD who suffer from chronic pain. Several studies have reported a decrease in O²Hb concentration in the regions below the electrodes and in other cortical areas during anodic or cathodic tDCS, which implies a risk factor for vasoocclusive events in individuals with SDC due to polymerization of hemoglobin when exposed to these low O²Hb concentrations. For this reasion, the aim main of this study is to assess the effect of a single session of transcranial direct current stimulation (tDCS) associated to peripheral electrical stimulation (PES) on safety and efficacy analgesic in individuals with sickle cell disease (SCD). Others aims sencondaries are evaluate the effect of a single session of transcranial direct current stimulation (tDCS) associated to peripheral electrical stimulation (PES) on biomarkers neurophysiological and inflammatory.
详细描述
Pain, in its various manifestations, is the symptom most often associated to SCD, being responsible for over 90% of hospital admissions. Oftenly pain has a major impact on the patient's life and is associated with some degree of disability. Chronic pain may reflect the continuity of tissue injury and central nervous system maladaptive plasticity. They start with tissue injuries such as leg ulcers, avascular osteonecrosis, chronic osteomyelitis, arthropathy, or even continue after the repair process, by central nervous sensitization and / or peripheral. The lack of diagnosis in cases of chronic and neuropathic pain in patients with SCD is common, implying inappropriate use of therapeutic resources by the health services, resulting in increased suffering to the patient. The release of inflammatory mediators is related to the perception of pain, and may cause nociceptor sensitization.
The tDCS has the potential to change the neuronal membrane resting potential, this effect is dependent on the polarity, being that cathode produces hyperpolarization, whereas anode produces depolarization, in this way can induce an effect of inhibition and facilitation of neuronal firing, respectively. This effects can induces changes in cortical excitability. Although tDCS may modulate areas related to endogenous pain control, its effects seem to be diffuse, and focality would probably enhance its effects. The peripheral electrical stimulation (PES), in another way, may also modulate cortical excitability, depending mainly on its amplitude and frequency. PES modulation of cortical excitability is very focal, occurring only in the stimulated region. The combination of these two neuromodulatory techniques has showed additive effects in some studies with individuals suffering from chronic pain,which promoting a general effect (tDCS), and the other a more focal effect (TENS). Although this additive effect has been demonstrated, to date, no study evaluate its safety and efficacy in individuals with DF.
As a secondary outcome, the investigators are going to access the influence of the intervention on quantitative electroencephalography (qEEG). Growing evidence points out to different brain characteristics between individuals with chronic pain and healthy. qEEG has high temporal resolution and evaluates primary electrical effects of neural excitation, allowing identify possible patterns of brain functioning in individuals with chronic pain. qEEG allowed the identification of the thalamocortical dysrhythmia (TCD) in patients with chronic pain characterized by an increased low frequency band power density theta (4 - 7Hz) and a decrease in high frequency bands alpha (8 -12Hz) and beta (13 - 30Hz). This dysrhythmic mechanism may occur from the periphery to the thalamus (bottom-up) or cortical dysregulation (top-down), disinhibition of the thalamus. This process results in hyperpolarization of thalamic neurons, leading to a preponderance of low frequency oscillations in qEEG. The persistence thalamic firing at low frequencies can lead to a collateral inhibition in cortical regions around, which could theoretically lead to a decrease in the higher frequencies. This increase occurs at low frequency regions involved in neuro matrix of pain.
The investigators will alse avaluate the influence of the chronic pain sencondary to avascular necrosis of hip joint about cortical motor reorganization using transcranial magnetic stimuation (TMS). Recent data point to a gluteus maximus muscle weakness during maximal voluntary contraction in pronation position in individuals with joint pain in the hip. Similarly, individuals with legg calve perthes who suffer from femoral head necrosis, weakness of the abductor hip musculature was related to poor clinical outcomes. A possible explanation for these findings is cortical motor reorganization, which is associated with motor control impairment, and this has been demonstrated in individuals with chronic lateral epicondylalgia and knee osteoarthritis, where cortical organization is altered and correlated positively with the time of Pain and is associated with the perpetuation of pain. This cortical reorganization can occur in the somatotopic areas corresponding to the motor or sensorial homunculus, having as characteristic an overlap, retraction and "blurring" in the somatotopic representation of a certain region.
The mediators released by cells of the immune and inflammatory system can act directly on neurons sensitizing and enabling them (usually peripheral nociceptors or neurons in the dorsal horn of the spinal cord). There are several mediators in a long and growing list that includes cytokines and neurotrophins.The major cytokines in an acute inflammation are the Tumor Necrosis Factor (TNF) and the interleukins (IL-1), IL-6 and IL-8, which are important mediators of acute and chronic inflammatory reactions, as well as processes of repair and resolution. High serum levels of IL-8 have been observed in patients in vase-occlusive crisis, important clinical aspect of the pathogenesis of SCD. The presence of the mutant allele A appears to influence the expression of the TNF-alpha, being the AA genotype considered a high producer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 50 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Being diagnosed with sickle cell disease hemoglobin electrophoresis.
- •Be aged 18 years old to 50 years old.
- •Having signed the consent form and clarified.
- •Having chronic pain with at least 3 months duration.
- •Being diagnosed with femoral head osteonecrosis
- •Have more than one type of chronic pain.
排除标准
- •Have cochlear implants, pacemakers or metallic implant in the skull / brain;
- •Have metallic implant application site of peripheral stimulation;
- •History of head trauma;
- •Pregnancy;
- •seizures or epilepsy History;
- •Being in drug use that modify neuronal activation threshold (eg antidepressants and anticonvulsants);
- •Having diagnosis of fibromyalgia, or any impairment to be confused with the symptoms of SCD;
- •Have pain confirmed neuropathic type.
研究组 & 干预措施
SS-tDCS (simulated) plus PES (active)
tDCS plus PES (n=15).
干预措施: tDCS plus PES (Device)
SS-tDCS (active) plus PES (active)
tDCS plus PES (n=15).
干预措施: tDCS plus PES (Device)
SS-tDCS (active) plus PES (simulated)
tDCS plus PES (n=15).
干预措施: tDCS plus PES (Device)
SS-tDCS (simulated) plus PES (simulated)
tDCS plus PES (n=15).
干预措施: tDCS plus PES (Device)
SC-tDCS (active) plus PES (active)
tDCS plus PES (n=15).
干预措施: tDCS plus PES (Device)
SC-tDCS (active) plus PES (simulated)
tDCS plus PES (n=15).
干预措施: tDCS plus PES (Device)
SC-tDCS (simulated) plus PES (active)
tDCS plus PES (n=15).
干预措施: tDCS plus PES (Device)
SC-tDCS (simulated) plus PES (simulated)
tDCS plus PES (n=15).
干预措施: tDCS plus PES (Device)
结局指标
主要结局
Change in pain intensity
时间窗: One day
Pain assessment at before and after each intervention: Actual pain intensity will be assessed using a 0-10 visual analogue scale (VAS), where 0 is no pain and 10 the worst imaginable pain. Visual analogue scale allows to evaluate the intensity pain of a quantitative way, the subjects will fill a VAS before and after treatment.
次要结局
- Motor cortical reorganization(One day)
- Analysis of brain waves delta, theta, alpha and beta(One day)
- Dosages of TNF-alpha and BDNF in patients with SCD(One day)
- Impact of pain in functionality(One day)
- Hospital anxiety and depression scale (HADS)(One day)
